| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0003 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.0004 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.0005 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0006 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0007 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.18 | 0.0009 |